OpenAlex
PricingAboutJobs
Log inGet started
Work

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Psychiatry
DOI: 10.4088/jcp.12m08160
Authors: Vladimir Lerner, Chanoch Miodownik, Anatoly Gibel, Pinchas Sirota, Ilan Bush, Hadi Elliot, Ruben Benatov, Michael S. Ritsner
Institution: Ben-Gurion University of the Negev
Language: English

Topic: Schizophrenia research and treatment
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: bexarotene, retinoid X receptor agonist, schizophrenia, schizoaffective disorder, positive symptoms, antipsychotic augmentation, lipid-lowering drugs, cholesterol, thyroxine, adverse effects, PANSS, quality of life, functioning, drug safety and tolerability, nuclear receptor signaling, treatment-resistant schizophrenia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2062768595
FWCI: 2.562
Cites: 56
Cited by: 54
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security